These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14050042)

  • 21. THE CHOICE OF HYPOTENSIVE AGENTS.
    PALMER KN
    Practitioner; 1964 Jul; 193():43-9. PubMed ID: 14194585
    [No Abstract]   [Full Text] [Related]  

  • 22. [CLINICAL OBSERVATIONS ON THE TREATMENT OF ARTERIAL HYPERTENSION WITH ALPHA-METHYLDOPA].
    COLAO G; SCARDINO R
    Rass Int Clin Ter; 1964 May; 44():471-82. PubMed ID: 14169660
    [No Abstract]   [Full Text] [Related]  

  • 23. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 24. alpha-Methyldopa and depression: a clinical study and review of the literature.
    DeMuth GW; Ackerman SH
    Am J Psychiatry; 1983 May; 140(5):534-8. PubMed ID: 6846579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-methyldopa: antihypertensive drug with unusual mechanism of action.
    SJOERDSMA A
    Heart Bull; 1963; 12():1-4. PubMed ID: 13977819
    [No Abstract]   [Full Text] [Related]  

  • 26. [ALPHA-METHYLDOPA, ALPHA-METHYLDOPA AND HYDROCHLOROTHIAZIDE, AND A PLACEBO IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION: "DOUBLE-BLIND" TEST].
    DELZAR LE; PALENCIA AE; CONTI LA; URRIBARRI R
    Dia Med; 1964 Mar; 36():98-9. PubMed ID: 14145577
    [No Abstract]   [Full Text] [Related]  

  • 27. [ALPHA-METHYLDOPA IN ARTERIAL HYPERTENSION. CLINICAL STUDY].
    PONCEDELEON JJ; CARRILLO AA; ZAMORA CG; NUNEZ EP
    Arch Inst Cardiol Mex; 1964; 34():197-211. PubMed ID: 14180413
    [No Abstract]   [Full Text] [Related]  

  • 28. [PHEOCHROMOCYTOMA AS A CAUSE OF CURABLE ARTERIAL HYPERTENSION. PRESENTATION OF A NEW CASE].
    RAPADOERRAZTI A; JIMENEZCASADO M; RODRIGUEZSANTOS A; NAVARRO V
    Rev Clin Esp; 1963 Aug; 90():247-51. PubMed ID: 14091050
    [No Abstract]   [Full Text] [Related]  

  • 29. [ACTION OF ALPHA-METHYLDOPA, ALONE AND COMBINED WITH HYDROCHLOROTHIAZIDE, IN THE TREATMENT OF SYSTEMIC ARTERIAL HYPERTENSION].
    DELZAR L; PALENCIA AE; CONTI LA; URRIBARRI R
    Dia Med; 1964 Apr; 36():320-3. PubMed ID: 14141749
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction between centrally acting hypotensive drugs and tricyclic antidepressants.
    van Zwieten PA
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):12-30. PubMed ID: 1156022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-methyldopa in hypertension.
    GOLDBERG B; LEVIN NW; RUBINSTEIN A; COHEN L
    S Afr Med J; 1963 Jul; 37():755-60. PubMed ID: 13948660
    [No Abstract]   [Full Text] [Related]  

  • 32. [THE MEDICAMENTOUS TREATMENT OF COMMON ARTERIAL HYPERTENSION].
    FRITEL D
    Rev Prat; 1963 Dec; 13():3999-4007. PubMed ID: 14100439
    [No Abstract]   [Full Text] [Related]  

  • 33. [DECARBOXYLASE INHIBITORS IN THE THERAPY OF ARTERIAL HYPERTENSION (L-ALPHA-METHYLDOPA)].
    BUONINCONTI R; JACONO A; VITALE P
    Minerva Med; 1963 Oct; 54():3169-74. PubMed ID: 14104505
    [No Abstract]   [Full Text] [Related]  

  • 34. ALPHA-METHYLDOPA IN ARTERIAL HYPERTENSION: CLINICAL, RENAL AND HEMODYNAMIC STUDIES.
    SANNERSTEDT R; BOJS G; VARNAUSKAS E; WERKOE L
    Acta Med Scand; 1963 Jul; 174():53-67. PubMed ID: 14042466
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhibition of serotonin formation by alpha-methyl-DOPA].
    WESTERMANN E; BALZER H; KNELL J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(3):194-205. PubMed ID: 13600388
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of alpha-methyl-dopa (Dopegyt) and other antihypertensive drugs (guanethidine, bethanidine) on the isotope renogram.
    Radó J; Bános C; Takó J; Szabó T; Borbély L; Szende L; Kapus I; Nagy M
    Ther Hung; 1969; 17(2):76-82. PubMed ID: 5807612
    [No Abstract]   [Full Text] [Related]  

  • 37. TREATMENT OF HYPERTENSION. THE SPECIAL PLACE OF ALPHA-METHYLDOPA. A SHORT TERM STUDY.
    WEIL MH; BARBOUR BH
    Calif Med; 1963 Sep; 99(3):178-81. PubMed ID: 14047631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THE PROLONGED USE OF ALPHA METHYLDOPA IN THE TREATMENT OF HYPERTENSION.
    RAFTOS J; JULIAN DG; VALENTINE PA
    Med J Aust; 1964 May; 1():837-42. PubMed ID: 14166702
    [No Abstract]   [Full Text] [Related]  

  • 39. Method for isolation and determination of alpha-methyl DOPA ethyl ester in aqueous solution.
    MARCUS AD; DEMARCO JD
    J Pharm Sci; 1963 Apr; 52():402-3. PubMed ID: 13932910
    [No Abstract]   [Full Text] [Related]  

  • 40. Long term comparative study of guanfacine and alpha-methyldopa in essential hypertension.
    Rengo F; Ricciardelli B; Volpe M; Trimarco B; Saccà L; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):281-91. PubMed ID: 6996627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.